Oligo Security Joins Palantir's FedStart Program for Enhanced Federal Security
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 hours ago
0mins
Source: Newsfilter
- Compliance Acceleration: By joining Palantir's FedStart program, Oligo Security accelerates its path to achieving FedRAMP High and DoD IL5 compliance, which is expected to significantly reduce the time required for federal agencies to deploy security measures, thereby enhancing government responsiveness to real-time protection.
- Innovative Real-Time Protection: Oligo's runtime security solution enables immediate identification and blocking of malicious behavior during attacks by actively monitoring applications, cloud workloads, and AI systems, transforming the traditional passive defense model of security tools and enhancing defenses against modern threats.
- Infrastructure Support: Through the FedStart program, Oligo will leverage Palantir's secure software development infrastructure and compliance frameworks to expedite the delivery of its innovative technology to federal clients while maintaining rigorous security standards, further expanding its market share.
- Government Collaboration Outlook: Oligo's participation not only provides opportunities for collaboration with government agencies but also signifies its strategic positioning in the rapidly evolving cybersecurity landscape, aiming to meet the urgent security needs of the government by delivering trusted solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PLTR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PLTR
Wall Street analysts forecast PLTR stock price to rise
17 Analyst Rating
5 Buy
10 Hold
2 Sell
Hold
Current: 130.630
Low
50.00
Averages
192.88
High
255.00
Current: 130.630
Low
50.00
Averages
192.88
High
255.00
About PLTR
Palantir Technologies Inc. is engaged in building software to assist in counterterrorism investigations and operations. The Company has built four principal software platforms, including Palantir Gotham (Gotham), Palantir Foundry (Foundry), Palantir Apollo (Apollo), and Palantir Artificial Intelligence Platform (AIP). Apollo is a cloud-agnostic, single control layer that coordinates ongoing delivery of new features, security updates, and platform configurations, helping to ensure the continuous operation of critical systems. Gotham enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants. Foundry transforms the ways organizations operate by creating a central operating system for their data. AIP enables responsible artificial intelligence (AI)-advantage across the enterprise by using primary, core components built to effectively activate large language models and other AI within any organization.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Palantir's Growth Accelerates Amid Stock Price Decline
- Significant Revenue Growth: Palantir's overall revenue rose 85% year-over-year in Q1, with U.S. commercial revenue increasing by 133% and government revenue by 84%, demonstrating strong performance in AI applications despite the stock price decline, indicating robust business fundamentals.
- High Profitability: The company achieved a 53% net income margin in Q1, positioning itself among the most profitable firms in the market, which underscores the effectiveness of its business model and the sustained strong demand in the market.
- Stock Price Misalignment with Earnings: Despite a nearly 40% drop in stock price, Palantir trades at a high P/E ratio of 87, while analysts project only a 42% increase in EPS from $1.47 in 2026 to $2.08 in 2027, raising concerns about the sustainability of its growth.
- Diminishing Investor Confidence: Growing apprehension among investors regarding Palantir's high valuation suggests that the current stock price reflects four years of anticipated growth, potentially leading to further selling pressure, prompting a cautious approach towards investing in the stock at this time.
See More
Four Stocks to Avoid Right Now
- Market Warning Signs: The stocks mentioned in the video showed poor performance on June 17, 2026, indicating potential downside risks that investors should be cautious about.
- Investor Attention: The video advises investors to pay attention to warning signs associated with these stocks to avoid significant losses, highlighting the importance of market volatility in investment decisions.
- Short-term Risk Assessment: The analysis suggests that the current market environment may lead to greater downside pressure on these stocks in the short term, prompting investors to reconsider their portfolios.
- Subscription and Offers: The video encourages viewers to subscribe to the channel and click on the special offer link, indicating the content creator's intention to provide more information to help investors make informed decisions.
See More
ChapsVision Establishes Independent Ethics Committee to Oversee Contracts
- Ethics Committee Authority: ChapsVision's independent ethics committee can block any contracts where its software may be misused, underscoring the importance of oversight as Europe seeks local alternatives to U.S. data analytics providers.
- Project Review Mechanism: The committee reviews projects based on OECD transparency indicators, the UN Charter, and European rules, ensuring the protection of privacy and civil liberties in sensitive data processing initiatives.
- Government Contract Progress: ChapsVision has secured government contracts in France and Germany, with a French project awarded in 2024 already operational across multiple ministries, expected to fully deploy within 18 to 24 months.
- Global Expansion Vision: ChapsVision aims for global reach, primarily collaborating with France's intelligence agency, while planning to extend ArgonOS to other countries to ensure compliance and ethical standards in sensitive data handling.
See More
Oligo Security Joins Palantir's FedStart Program for Enhanced Federal Security
- Compliance Acceleration: By joining Palantir's FedStart program, Oligo Security accelerates its path to achieving FedRAMP High and DoD IL5 compliance, which is expected to significantly reduce the time required for federal agencies to deploy security measures, thereby enhancing government responsiveness to real-time protection.
- Innovative Real-Time Protection: Oligo's runtime security solution enables immediate identification and blocking of malicious behavior during attacks by actively monitoring applications, cloud workloads, and AI systems, transforming the traditional passive defense model of security tools and enhancing defenses against modern threats.
- Infrastructure Support: Through the FedStart program, Oligo will leverage Palantir's secure software development infrastructure and compliance frameworks to expedite the delivery of its innovative technology to federal clients while maintaining rigorous security standards, further expanding its market share.
- Government Collaboration Outlook: Oligo's participation not only provides opportunities for collaboration with government agencies but also signifies its strategic positioning in the rapidly evolving cybersecurity landscape, aiming to meet the urgent security needs of the government by delivering trusted solutions.
See More
Latest Wall Street Rating Updates
- Apple Rating Reaffirmed: Bank of America reiterates Apple as a buy, believing that price increases are already reflected in the stock, anticipating that rising memory costs will force Apple to raise prices, impacting future earnings performance.
- Nice Upgrade: DA Davidson upgrades Nice from neutral to buy, maintaining a $110 price target, arguing that concerns about AI disruption are overblown, suggesting a more optimistic outlook that could boost the company's stock price.
- Immix Biopharma Initiation: Bank of America initiates coverage of Immix Biopharma with a buy rating and a $27 price target, citing the company's differentiated product offerings as a significant growth driver.
- Salesforce Upgrade: Monness Crespi Hardt upgrades Salesforce from neutral to buy with a $200 price target, based on its depressed valuation, strong cash flow generation, and support for customer transformation, which are expected to drive stock price increases.
See More
US Stocks Plunge as Tech Sector Weighs Down Market
- Market Weakness: On Wednesday, the S&P 500 Index fell by 1.21%, the Dow Jones Industrial Average dropped by 0.98%, and the Nasdaq 100 Index declined by 0.99%, reflecting market concerns over potential interest rate hikes by the Fed, particularly amid weak performance in technology stocks.
- Economic Data Support: Despite the market downturn, US May retail sales rose by 0.9% month-over-month, surpassing expectations of 0.6%, indicating resilient consumer demand, while pending home sales increased by 3.8% month-over-month, marking the largest gain in 20 months, potentially providing some support to the market.
- Fed Policy Outlook: The Fed maintained interest rates at its meeting on Wednesday but indicated through its dot plot that at least one more 25 basis point hike is expected this year, with the 2026 year-end federal funds rate projection raised to 3.75%, reflecting a cautious outlook on future economic conditions.
- International Market Response: While US stocks declined, overseas markets performed strongly, with the Euro Stoxx 50 reaching a new record high and closing up 0.68%, demonstrating global investor confidence in economic recovery, which may contrast with the US market's performance.
See More
Palantir's Growth Accelerates Amid Stock Price Decline
- Significant Revenue Growth: Palantir's overall revenue rose 85% year-over-year in Q1, with U.S. commercial revenue increasing by 133% and government revenue by 84%, demonstrating strong performance in AI applications despite the stock price decline, indicating robust business fundamentals.
- High Profitability: The company achieved a 53% net income margin in Q1, positioning itself among the most profitable firms in the market, which underscores the effectiveness of its business model and the sustained strong demand in the market.
- Stock Price Misalignment with Earnings: Despite a nearly 40% drop in stock price, Palantir trades at a high P/E ratio of 87, while analysts project only a 42% increase in EPS from $1.47 in 2026 to $2.08 in 2027, raising concerns about the sustainability of its growth.
- Diminishing Investor Confidence: Growing apprehension among investors regarding Palantir's high valuation suggests that the current stock price reflects four years of anticipated growth, potentially leading to further selling pressure, prompting a cautious approach towards investing in the stock at this time.
See More
Four Stocks to Avoid Right Now
- Market Warning Signs: The stocks mentioned in the video showed poor performance on June 17, 2026, indicating potential downside risks that investors should be cautious about.
- Investor Attention: The video advises investors to pay attention to warning signs associated with these stocks to avoid significant losses, highlighting the importance of market volatility in investment decisions.
- Short-term Risk Assessment: The analysis suggests that the current market environment may lead to greater downside pressure on these stocks in the short term, prompting investors to reconsider their portfolios.
- Subscription and Offers: The video encourages viewers to subscribe to the channel and click on the special offer link, indicating the content creator's intention to provide more information to help investors make informed decisions.
See More
ChapsVision Establishes Independent Ethics Committee to Oversee Contracts
- Ethics Committee Authority: ChapsVision's independent ethics committee can block any contracts where its software may be misused, underscoring the importance of oversight as Europe seeks local alternatives to U.S. data analytics providers.
- Project Review Mechanism: The committee reviews projects based on OECD transparency indicators, the UN Charter, and European rules, ensuring the protection of privacy and civil liberties in sensitive data processing initiatives.
- Government Contract Progress: ChapsVision has secured government contracts in France and Germany, with a French project awarded in 2024 already operational across multiple ministries, expected to fully deploy within 18 to 24 months.
- Global Expansion Vision: ChapsVision aims for global reach, primarily collaborating with France's intelligence agency, while planning to extend ArgonOS to other countries to ensure compliance and ethical standards in sensitive data handling.
See More
Oligo Security Joins Palantir's FedStart Program for Enhanced Federal Security
- Compliance Acceleration: By joining Palantir's FedStart program, Oligo Security accelerates its path to achieving FedRAMP High and DoD IL5 compliance, which is expected to significantly reduce the time required for federal agencies to deploy security measures, thereby enhancing government responsiveness to real-time protection.
- Innovative Real-Time Protection: Oligo's runtime security solution enables immediate identification and blocking of malicious behavior during attacks by actively monitoring applications, cloud workloads, and AI systems, transforming the traditional passive defense model of security tools and enhancing defenses against modern threats.
- Infrastructure Support: Through the FedStart program, Oligo will leverage Palantir's secure software development infrastructure and compliance frameworks to expedite the delivery of its innovative technology to federal clients while maintaining rigorous security standards, further expanding its market share.
- Government Collaboration Outlook: Oligo's participation not only provides opportunities for collaboration with government agencies but also signifies its strategic positioning in the rapidly evolving cybersecurity landscape, aiming to meet the urgent security needs of the government by delivering trusted solutions.
See More
Latest Wall Street Rating Updates
- Apple Rating Reaffirmed: Bank of America reiterates Apple as a buy, believing that price increases are already reflected in the stock, anticipating that rising memory costs will force Apple to raise prices, impacting future earnings performance.
- Nice Upgrade: DA Davidson upgrades Nice from neutral to buy, maintaining a $110 price target, arguing that concerns about AI disruption are overblown, suggesting a more optimistic outlook that could boost the company's stock price.
- Immix Biopharma Initiation: Bank of America initiates coverage of Immix Biopharma with a buy rating and a $27 price target, citing the company's differentiated product offerings as a significant growth driver.
- Salesforce Upgrade: Monness Crespi Hardt upgrades Salesforce from neutral to buy with a $200 price target, based on its depressed valuation, strong cash flow generation, and support for customer transformation, which are expected to drive stock price increases.
See More
US Stocks Plunge as Tech Sector Weighs Down Market
- Market Weakness: On Wednesday, the S&P 500 Index fell by 1.21%, the Dow Jones Industrial Average dropped by 0.98%, and the Nasdaq 100 Index declined by 0.99%, reflecting market concerns over potential interest rate hikes by the Fed, particularly amid weak performance in technology stocks.
- Economic Data Support: Despite the market downturn, US May retail sales rose by 0.9% month-over-month, surpassing expectations of 0.6%, indicating resilient consumer demand, while pending home sales increased by 3.8% month-over-month, marking the largest gain in 20 months, potentially providing some support to the market.
- Fed Policy Outlook: The Fed maintained interest rates at its meeting on Wednesday but indicated through its dot plot that at least one more 25 basis point hike is expected this year, with the 2026 year-end federal funds rate projection raised to 3.75%, reflecting a cautious outlook on future economic conditions.
- International Market Response: While US stocks declined, overseas markets performed strongly, with the Euro Stoxx 50 reaching a new record high and closing up 0.68%, demonstrating global investor confidence in economic recovery, which may contrast with the US market's performance.
See More
